Neuland Laboratories elevates Saradhi Bolli to Global Head of CDMO Business Development

Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services

FDA pushes forward on gene-editing therapies with new safety roadmap

Genome editing holds extraordinary promise for treating previously incurable genetic diseases

Precision BioSciences expands Hepatitis B gene editing trial into France and Romania

The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania

Stereotaxis to acquire Robocath in deal aimed at expanding surgical robotics platform

Galderma rolls out next-generation regenerating skin nectar

Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection

Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions

NIPER Mohali, Novartis Healthcare sign pact to boost pharma R&D innovation

The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs

Rubicon forays into India's CNS segment with Rs 175.92 crore Arinna buy

Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%

Zydus Wellness appoints Adhir Anand as Head of Media & Digital

Former Wavemaker executive to lead media strategy and digital transformation agenda

Aurigene, Alveus advance obesity pipeline with ALV-200 candidate nomination

The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities